幼年型粒单核细胞白血病中NF1抑癌基因的双等位失活:驱动功能的遗传学证据及对诊断检查的意义
该研究在25例伴1型神经纤维瘤病(NF-1)的幼年型粒单核细胞白血病(JMML)患者和16例无NF-1临床征象且JMML相关驱动基因(PTPN11、KRAS、NRAS或CBL)无变异的JMML-5neg患者中,检测白血病细胞NF1双等位失活(“二次打击”)。结果显示NF-1临床诊断可靠提示NF1驱动型JMML亚型,即使无NF-1临床证据,JMML遗传学检查也应包括仔细的NF1分析。
要点
- 25例JMML/NF-1中,10例为NF1功能丧失变异合并17q单亲二体,5例为微缺失合并致病NF1变异,9例为双重杂合NF1变异。
- 16例无NF-1临床征象且JMML-5neg患者中,8例检出NF1变异:3例微缺失合并半合子NF1变异、3例双重杂合、2例杂合。
- 两组均常见继发性ASXL1和/或SETBP1变异。
核心结论
- JMML/NF-1的临床诊断可靠地提示NF1驱动型JMML亚型。
- 即使无NF-1临床证据,JMML的遗传学检查也应包括仔细的NF1分析。
研究设计与样本
- 研究检测25例伴NF-1的JMML患者和16例无NF-1临床征象且PTPN11、KRAS、NRAS或CBL无变异的JMML-5neg患者白血病细胞中的NF1双等位失活。
主要发现
- 25例JMML/NF-1中,10例存在NF1功能丧失变异合并17q臂单亲二体,5例存在NF1微缺失合并致病NF1变异,9例携带两个复合杂合NF1变异。
- 16例JMML-5neg中,8例检出NF1变异:3例微缺失合并半合子NF1变异,3例复合杂合NF1变异,2例杂合NF1变异。
- 两组均观察到继发性ASXL1和/或SETBP1变异的高发生率。
临床怎么用
- 作者结论认为,JMML/NF-1的临床诊断可靠地提示NF1驱动型JMML亚型。
- 作者结论认为,即使无NF-1临床证据,JMML的遗传学检查也应包括仔细的NF1分析。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Juvenile myelomonocytic leukaemia (JMML) is characterized by gene variants that deregulate the RAS signalling pathway. Children with neurofibromatosis type 1 (NF-1) carry a defective NF1 allele in the germline and are predisposed to JMML, which presumably requires somatic inactivation of the NF1 wild-type allele. Here we examined the two-hit concept in leukaemic cells of 25 patients with JMML and NF-1. Ten patients with JMML/NF-1 exhibited a NF1 loss-of-function variant in combination with uniparental disomy of the 17q arm. Five had NF1 microdeletions combined with a pathogenic NF1 variant and nine carried two compound-heterozygous NF1 variants. We also examined 16 patients without clinical signs of NF-1 and no variation in the JMML-associated driver genes PTPN11, KRAS, NRAS or CBL (JMML-5neg) and identified eight patients with NF1 variants. Three patients had microdeletions combined with hemizygous NF1 variants, three had compound-heterozygous NF1 variants and two had heterozygous NF1 variants. In addition, we found a high incidence of secondary ASXL1 and/or SETBP1 variants in both groups. We conclude that the clinical diagnosis of JMML/NF-1 reliably indicates a NF1-driven JMML subtype, and that careful NF1 analysis should be included in the genetic workup of JMML even in the absence of clinical evidence of NF-1.
引用
- Ramamoorthy S, Lebrecht D, Schanze D, et al. Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup. Br J Haematol. 2023. PMID: 37945316. doi:10.1111/bjh.19190
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。